Last Price | 2.51 | Max Price | 6.31 |
Min Price | 2.47 | 1 Year return | -59.65 |
Sector | Health Care | Subsector | Pharmaceuticals |
Contact info:Street: 10-12 boulevard Marius Vivier MerlePostbox: 69003Country: FrancePhone: +33 4 78 76 61 01 Website: www.valneva.com
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 126 | 615,634 | 0.02 % |
2020 | 110 | 638,070 | 0.02 % |
2021 | 348 | 727,968 | 0.05 % |
2022 | 361 | 787,273 | 0.05 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
No Records Found
The company mostly operates in the pharmaceutical sector. The global pharmaceutical companies gained over the past 10 years on average 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.
The period between December 2015 and December 2016 was a bad period for the investors. The stock lost almost 25 percent. Over the past 5 years Valneva' stock lost at around 31 percent in value.
Valneva didn't pay out any dividends (in the past 5 years).
At the end of 2015 the pharmaceutical company's balance sheet equaled 0 million euros. Of the total balance sheet 0 million euros ( percent) was financed by debt.
On this page you can find all Valneva's financial reports. More information about Valneva can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
78
|
94
|
105
|
113
|
126
|
110
|
Costs |
99
|
143
|
117
|
110
|
128
|
175
|
Profit |
-21
|
-49
|
-11
|
3
|
-2
|
-64
|
Margin of profit |
-26.31
|
-52.29
|
-10.90
|
2.88
|
-1.38
|
-58.37
|
ROI |
-14.29
|
-49.16
|
-12.39
|
2.28
|
-1.29
|
-83.17
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
144
|
100
|
93
|
143
|
135
|
77
|
Debt |
131
|
107
|
97
|
87
|
130
|
372
|
Total assets |
275
|
207
|
189
|
230
|
265
|
449
|
Solvency |
52.45
|
48.36
|
48.94
|
62.28
|
51.05
|
17.24
|
Cash |
42
|
35
|
34
|
77
|
64
|
204
|
Cashflow |
-24
|
7
|
13
|
16
|
6
|
138
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
-0.19
|
0.06
|
0.13
|
0.19
|
0.04
|
0.37
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
3.80
|
3.09
|
2.77
|
3.17
|
2.57
|
Eps |
-0.66
|
-0.15
|
0.04
|
-0.02
|
-0.71
|
Price/earnings-ratio |
-5.76
|
-20.60
|
69.25
|
-158.50
|
-3.54
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
1.29
|
1.20
|
1.58
|
1.49
|
0.85
|
Market to book |
0.34
|
0.39
|
0.57
|
0.47
|
0.34
|
Cashflow per stock |
0.08
|
0.17
|
0.18
|
0.06
|
1.52
|
Stocks |
77
|
77
|
91
|
91
|
91
|
Market Cap |
294.35
|
239.15
|
251.50
|
287.90
|
227.97
|
Date
|
Price
|
---|---|
08 Nov 2024
|
2.51
|
05 Nov 2024
|
2.64
|
31 Oct 2024
|
2.67
|
29 Oct 2024
|
2.79
|
23 Oct 2024
|
2.73
|
19 Oct 2024
|
2.66
|
16 Oct 2024
|
2.47
|
14 Oct 2024
|
2.52
|
05 Oct 2024
|
2.61
|
02 Oct 2024
|
2.60
|
27 Sep 2024
|
2.75
|
20 Sep 2024
|
2.67
|
17 Sep 2024
|
2.77
|
13 Sep 2024
|
3.14
|
28 Aug 2024
|
3.38
|
26 Aug 2024
|
3.48
|
23 Aug 2024
|
3.36
|
11 Aug 2024
|
3.11
|
07 Aug 2024
|
3.16
|
05 Aug 2024
|
3.03
|
01 Aug 2024
|
3.30
|
30 Jul 2024
|
3.26
|
26 Jul 2024
|
3.25
|
23 Jul 2024
|
3.46
|
16 Jul 2024
|
3.36
|
10 Jul 2024
|
3.35
|
09 Jul 2024
|
3.19
|
04 Jul 2024
|
3.23
|
02 Jul 2024
|
3.41
|
26 Jun 2024
|
3.41
|